Renal transplantation vs hemodialysis: Cost-effectiveness analysis

Vojnosanitetski Pregled

Volumn 66, Issue 8, 2009, Pages 639-644

  Perović, Saša ^a   Janković, Slobodan ^b  

^a Republic Institute for Health Insurance   (Serbia)

^b Institute of Physiology   (Serbia)

Author keywords

Costs and cost analysis; Dialysis; Kidney failure, chronic; Questionnaries

Indexed keywords

ADULT; ARTICLE; COST CONTROL; COST EFFECTIVENESS ANALYSIS; HEMODIALYSIS; HUMAN; INTERMETHOD COMPARISON; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MONEY; PSYCHOLOGICAL ASPECT; QUALITY ADJUSTED LIFE YEAR; SERBIA; SYMPTOM; WELLBEING;

EID: 69249149970     PISSN: 00428450     EISSN: None     Source Type: Journal    
DOI: 10.2298/VSP0908639P     Document Type: Article

References (19)

1. Oštrić VZ, Crossed D signukanović Lj, Jovanović D, Dimković N. Innovations in nefrology. 2001; 6: 45-80.
2. Plješa, S. Kidney and urinary tract diseases. In: Manojlović D. Editor. Internal medicine. Belgrade: Zavod za udžbenike i nastavna sredstva; 1998. p. 1501-1505
3. Plješa, S. Renal cystic diseases in grown up persons. Srpski arhiv za celokupno lekarstvo; 1996. 124 Suppl: 235-241
4. Plješa, S. Inherent kidney diseases. In: Crossed D signukanović Lj, Oštrić V, editors. Kidney diseases. Belgrade: Zavod za udžbenike i nastavna sredstva, 1999; p. 404-409
5. Colleen B, Zak RN. Polycystic kidney disease: An overview and commentary. Dialysis&Transplantation 1999; 28(8): 468-474 S.
6. Paunović G, Paunović K, Kostić S, Veličković R, Avramović M. Kidney transplantation in Serbia-prospectsat the turn of 21st century. Acta Medica Medianae 2004; 43(3): 55-58
7. Ponticelli C, Civati G, Tarantino A, Quarto di Palo F, Corbetta G, Minetti L, et al. Randomized study with cyclosporine in kidney transplantation: 10-year follow-up. J Am Soc Nephrol 1996; 7(5): 792-797 (Pubitemid 27466014)
8. Regulation of coefficients for calculation and payment of salaries of employed in public services ("Official Gazette of RS", nos. 44/2001, 15/2002 - second regulation*, 30/2002, 32/2002-correction,69/2002, 78/2002, 61/2003, 121/2003,130/2003, 67/2004, 120/2004, 5/2005, 26/2005, 81/2005, 105/2005, 109/2005, 27/2006, 32/2006, 58/2006, 82/2006, 106/2006, 10/2007,40/2007 and 60/2007)
9. Regulation of Drug List prescribed and charged to the compulsory Health Insurance Funds ("Official Gazette of RS", nos. 127/07, 09/08 - correction, 51/08, 78/08 82/08 - correction).
10. Regulation of material costs validation for dialysis charged to the compulsory Health Insurance Funds ("Official Gazette of RS", nos. 50/06)World Health Organization. Ministry of Health of Republic Serbia. Better Health for All in the Third Millennium. 2003.
11. Annual report on management of renal failure in Europe. EDTA/ERA XXX; 1999.
12. Republic Bureau of Statistics. Population statistics. Report No. 295,2002.
13. Jassal SV, Krahn MD, Naglie G, Zaltzman JS, Roscoe JM, Cole EH, et al. Kidney transplantation in the elderly: a decision analysis. J Am Soc Nephrol 2003; 14(1): 187-196 (Pubitemid 36026309)
14. Loubeau PR, Loubeau JM, Jantzen R. The economics of kidney transplantation versus hemodialysis. Prog Transplant 2001; 11(4): 291-297 (Pubitemid 34000694)
15. Klarman HE, Francis JO, Rosenthal GD. Cost-effectiveness analysis applied to the treatment of chronic renal disease. Med Care 1968; 6: 48-54.
16. Kaló Z, Járay J, Nagy J. Economic evaluation of kidney transplantation versus hemodialysis in patients with end-stage renal disease in Hungary. Prog Transplant 2001; 11(3): 188-193 (Pubitemid 32896627)
17. Japanese Society for Dialysis Therapy. Overview of regular dialysis treatment in Japan. The Institut of Tokyo; 2005.
18. Kaminota M. Cost-effectiveness analysis of dialysis and kidney transplants in Japan. Keio J Med 2001; 50(2): 100-108 (Pubitemid 33611659)
19. UK Transplant Press Release 287/03 - 7 December 2003. (Charity Number 1106735).